BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34013366)

  • 1. Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).
    Liu YR; Wang JQ; Huang ZG; Chen RN; Cao X; Zhu DC; Yu HX; Wang XR; Zhou HY; Xia Q; Li J
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy.
    Shetty MG; Pai P; Deaver RE; Satyamoorthy K; Babitha KS
    Pharmacol Res; 2021 Aug; 170():105695. PubMed ID: 34082029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis.
    Li M; Zheng Y; Yuan H; Liu Y; Wen X
    Int Immunopharmacol; 2017 Nov; 52():272-280. PubMed ID: 28961490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
    Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism.
    Moonat S; Sakharkar AJ; Zhang H; Tang L; Pandey SC
    Biol Psychiatry; 2013 Apr; 73(8):763-73. PubMed ID: 23485013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.
    Khan DH; Gonzalez C; Cooper C; Sun JM; Chen HY; Healy S; Xu W; Smith KT; Workman JL; Leygue E; Davie JR
    Nucleic Acids Res; 2014 Feb; 42(3):1656-70. PubMed ID: 24234443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation.
    Ma P; Schultz RM
    Cell Death Differ; 2016 Jul; 23(7):1119-27. PubMed ID: 27082454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase-2 is involved in stress-induced cognitive impairment via histone deacetylation and PI3K/AKT signaling pathway modification.
    Wu J; Liu C; Zhang L; Qu CH; Sui XL; Zhu H; Huang L; Xu YF; Han YL; Qin C
    Mol Med Rep; 2017 Aug; 16(2):1846-1854. PubMed ID: 28656275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway.
    Liu C; Zhang Y; Li J; Wang Y; Ren F; Zhou Y; Wu Y; Feng Y; Zhou Y; Su F; Jia B; Wang D; Chang Z
    J Biol Chem; 2015 Apr; 290(15):9701-13. PubMed ID: 25697359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
    Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation.
    Turgeon N; Blais M; Gagné JM; Tardif V; Boudreau F; Perreault N; Asselin C
    PLoS One; 2013; 8(9):e73785. PubMed ID: 24040068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.
    Zhao J; Gray SG; Greene CM; Lawless MW
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):247-256. PubMed ID: 30791763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.
    You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J
    FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC2 regulates chromatin plasticity and enhances DNA vulnerability.
    Marchion DC; Bicaku E; Turner JG; Schmitt ML; Morelli DR; Munster PN
    Mol Cancer Ther; 2009 Apr; 8(4):794-801. PubMed ID: 19372552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulations of Histone Deacetylase 2 Offer a Protective Effect through the Mitochondrial Apoptosis Pathway in Acute Liver Failure.
    Wang Y; Yang F; Jiao FZ; Chen Q; Zhang WB; Wang LW; Gong ZJ
    Oxid Med Cell Longev; 2019; 2019():8173016. PubMed ID: 31183000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histone deacetylase on nonalcoholic fatty liver disease.
    Fu S; Yu M; Tan Y; Liu D
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):353-361. PubMed ID: 33213187
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex.
    Park HG; Yu HS; Park S; Ahn YM; Kim YS; Kim SH
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1487-500. PubMed ID: 24606669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.